Merck’s Stock is Suddenly Soaring, but Is the Struggling Healthcare Giant a Buy?
Merck shares began peeling back in early 2024, mostly on concerns about looming patent expirations for its breadwinning…
Some Georgians could soon be paying double for their medications – WSB-TV Channel 2
ATLANTA — In just a matter of days, President Donald Trump’s pharmaceutical tariff policy will go into effect,…